A Study of YTS109 Cell in Subjects With Relapsed/Refractory Autoimmune Hemolytic Anemia
NCT07287930
·
clinicaltrials.gov ↗
PHASE1
Phase
NOT_YET_RECRUITING
Status
13
Enrollment
OTHER
Sponsor class
Conditions
Autoimmune Hemolytic Anemia
Interventions
DRUG:
YTS109 cell
Sponsor
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Collaborators
[object Object]